Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Barbara Eichhorst(University of Cologne), Ulrich Mey(Kantonsspital Graubünden), Peter Hillmen(Leeds Teaching Hospitals NHS Trust), Carsten Utoft Niemann(University of Copenhagen), Arnon P. Kater(Amsterdam University Medical Centers), Emili Montserrat(Universitat de Barcelona), Michael Hallek(Integrated Oncology (United States)), Tadeusz Robak(Medical University of Lodz), Paolo Ghia(Vita-Salute San Raffaele University), Florence Cymbalista(Hôpital Avicenne), Michael Gregor(University of Lucerne), Christian Buske(University Hospital Ulm)
Annals of Oncology
October 19, 2020
10.1016/j.annonc.2020.09.019
Cited by 568

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k